Kim CH - Search Results

1

Curvature-sensing peptide inhibits tumour-derived exosomes for enhanced cancer immunotherapy.

Shin S, Ko H, Kim CH, Yoon BK, Son S, Lee JA, Shin JM, Lee J, Song SH, Jackman JA, Park JH. Shin S, et al. Among authors: kim ch. Nat Mater. 2023 May;22(5):656-665. doi: 10.1038/s41563-023-01515-2. Epub 2023 Mar 23. Nat Mater. 2023. PMID: 36959501

2

Chemiluminescence resonance energy transfer-based nanoparticles for quantum yield-enhanced cancer phototheranostics.

Jeon J, You DG, Um W, Lee J, Kim CH, Shin S, Kwon S, Park JH. Jeon J, et al. Among authors: kim ch. Sci Adv. 2020 May 20;6(21):eaaz8400. doi: 10.1126/sciadv.aaz8400. eCollection 2020 May. Sci Adv. 2020. PMID: 32637587 Free PMC article.

3

Cavitation-Inducible Mesoporous Silica-Titania Nanoparticles for Cancer Sonotheranostics.

Lee J, Kim JH, You DG, Kim S, Um W, Jeon J, Kim CH, Joo H, Yi GR, Park JH. Lee J, et al. Among authors: kim ch, kim s, kim jh. Adv Healthc Mater. 2020 Oct;9(19):e2000877. doi: 10.1002/adhm.202000877. Epub 2020 Sep 7. Adv Healthc Mater. 2020. PMID: 32893995

4

Recent advances in nanomaterial-based augmented sonodynamic therapy of cancer.

Um W, E K PK, Lee J, Kim CH, You DG, Park JH. Um W, et al. Among authors: kim ch. Chem Commun (Camb). 2021 Mar 18;57(23):2854-2866. doi: 10.1039/d0cc07750j. Chem Commun (Camb). 2021. PMID: 33625416 Review.

5

Bioorthogonally surface-edited extracellular vesicles based on metabolic glycoengineering for CD44-mediated targeting of inflammatory diseases.

Lim GT, You DG, Han HS, Lee H, Shin S, Oh BH, Kumar EKP, Um W, Kim CH, Han S, Lee S, Lim S, Yoon HY, Kim K, Kwon IC, Jo DG, Cho YW, Park JH. Lim GT, et al. Among authors: kim ch, kim k. J Extracell Vesicles. 2021 Mar;10(5):e12077. doi: 10.1002/jev2.12077. Epub 2021 Mar 12. J Extracell Vesicles. 2021. PMID: 33738083 Free PMC article.

6

Repurposing macitentan with nanoparticle modulates tumor microenvironment to potentiate immune checkpoint blockade.

Son S, Shin JM, Shin S, Kim CH, Lee JA, Ko H, Lee ES, Jung JM, Kim J, Park JH. Son S, et al. Among authors: kim ch, kim j. Biomaterials. 2021 Sep;276:121058. doi: 10.1016/j.biomaterials.2021.121058. Epub 2021 Aug 5. Biomaterials. 2021. PMID: 34399119

7

An anti-DR5 antibody-curcumin conjugate for the enhanced clearance of activated hepatic stellate cells.

Nguyen VQ, You DG, Kim CH, Kwon S, Um W, Oh BH, An JY, Jeon J, Park JH. Nguyen VQ, et al. Among authors: kim ch. Int J Biol Macromol. 2021 Dec 1;192:1231-1239. doi: 10.1016/j.ijbiomac.2021.09.176. Epub 2021 Oct 6. Int J Biol Macromol. 2021. PMID: 34626726

8

Sulfisoxazole Elicits Robust Antitumour Immune Response Along with Immune Checkpoint Therapy by Inhibiting Exosomal PD-L1.

Shin JM, Lee CH, Son S, Kim CH, Lee JA, Ko H, Shin S, Song SH, Park SS, Bae JH, Park JM, Choe EJ, Baek MC, Park JH. Shin JM, et al. Among authors: kim ch. Adv Sci (Weinh). 2022 Feb;9(5):e2103245. doi: 10.1002/advs.202103245. Epub 2021 Dec 20. Adv Sci (Weinh). 2022. PMID: 34927389 Free PMC article.

9

Recruitment of dendritic cells using 'find-me' signaling microparticles for personalized cancer immunotherapy.

Lee JA, Shin JM, Song SH, Kim CH, Son S, Shin S, Park JH. Lee JA, et al. Among authors: kim ch. Biomaterials. 2022 Mar;282:121412. doi: 10.1016/j.biomaterials.2022.121412. Epub 2022 Feb 15. Biomaterials. 2022. PMID: 35184011

10

Functional Extracellular Vesicles for Regenerative Medicine.

Kim HY, Kwon S, Um W, Shin S, Kim CH, Park JH, Kim BS. Kim HY, et al. Among authors: kim bs, kim ch. Small. 2022 Sep;18(36):e2106569. doi: 10.1002/smll.202106569. Epub 2022 Mar 23. Small. 2022. PMID: 35322545 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,748 results

Search Page